First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine ; day:11 ; month:6 ; year:2021 ; pages:1-4
Journal of neurology ; (11.6.2021), 1-4
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-021-10648-w
- URN
-
urn:nbn:de:101:1-2021100307344206863021
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Havla, Joachim
- Schultz, Yannick
- Zimmermann, Hanna
- Hohlfeld, Reinhard
- Danek, Adrian
- Kümpfel, Tania
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Pfizer
Evidence of abnormal trading on COVID-19 Pfizer vaccine development information
Reactivation of minimal change disease after Pfizer vaccine against COVID-19
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Pfizer, Luise; Kuhn, Maria, geb. Pfizer (USA)
Pfizer, Theodor
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Pfizer
Evidence of abnormal trading on COVID-19 Pfizer vaccine development information
Reactivation of minimal change disease after Pfizer vaccine against COVID-19
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Pfizer, Luise; Kuhn, Maria, geb. Pfizer (USA)
Pfizer, Theodor
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Pfizer
Evidence of abnormal trading on COVID-19 Pfizer vaccine development information
Reactivation of minimal change disease after Pfizer vaccine against COVID-19
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Pfizer, Luise; Kuhn, Maria, geb. Pfizer (USA)